Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07453927) titled 'Blue Light for Donor Site Healing in Burn Patients' on March 2.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: AUSL Romagna Rimini
Condition:
Donor Site Complication
Burn
Photobiomodulation Therapy
Blue Light
Intervention:
Device: Photobiomodulation with blue light
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: September 29, 2025
Target Sample Size: 25
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT0745392...